MICATRIO

This brand name is authorized in Japan

Active ingredients

The drug MICATRIO contains a combination of these active pharmaceutical ingredients (APIs):

1 Telmisartan UNII U5SYW473RQ - TELMISARTAN
Telmisartan is an orally active and specific angiotensin II receptor (type AT₁) antagonist. Telmisartan selectively binds the AT₁ receptor. The binding is long-lasting. Read about Telmisartan
2 Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE
Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle. Read about Amlodipine
3 Hydrochlorothiazide UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. Read about Hydrochlorothiazide

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: JP	医薬品医療機器総合機構	Identifier(s): 2149122F1026

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.